HK1210804A1 - Inducible coexpression system - Google Patents

Inducible coexpression system

Info

Publication number
HK1210804A1
HK1210804A1 HK15111422.8A HK15111422A HK1210804A1 HK 1210804 A1 HK1210804 A1 HK 1210804A1 HK 15111422 A HK15111422 A HK 15111422A HK 1210804 A1 HK1210804 A1 HK 1210804A1
Authority
HK
Hong Kong
Prior art keywords
inducible coexpression
coexpression system
inducible
coexpression
Prior art date
Application number
HK15111422.8A
Other languages
English (en)
Chinese (zh)
Inventor
Sean Mcclain
Mark Valasek
Original Assignee
Absci Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absci Llc filed Critical Absci Llc
Publication of HK1210804A1 publication Critical patent/HK1210804A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y503/00—Intramolecular oxidoreductases (5.3)
    • C12Y503/04—Intramolecular oxidoreductases (5.3) transposing S-S bonds (5.3.4)
    • C12Y503/04001—Protein disulfide-isomerase (5.3.4.1), i.e. disufide bond-forming enzyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02003—Glutathione synthase (6.3.2.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)
  • Two-Way Televisions, Distribution Of Moving Picture Or The Like (AREA)
  • Slot Machines And Peripheral Devices (AREA)
HK15111422.8A 2012-08-05 2015-11-19 Inducible coexpression system HK1210804A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261679751P 2012-08-05 2012-08-05
US201261747246P 2012-12-29 2012-12-29
PCT/US2013/053562 WO2014025663A1 (en) 2012-08-05 2013-08-05 Inducible coexpression system

Publications (1)

Publication Number Publication Date
HK1210804A1 true HK1210804A1 (en) 2016-05-06

Family

ID=49111529

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111422.8A HK1210804A1 (en) 2012-08-05 2015-11-19 Inducible coexpression system

Country Status (12)

Country Link
US (8) US9617335B2 (xx)
EP (4) EP3591057B9 (xx)
JP (3) JP6457387B2 (xx)
CN (2) CN104603274B (xx)
AU (3) AU2013299910B2 (xx)
CA (1) CA2880285C (xx)
DK (2) DK2880168T3 (xx)
ES (3) ES2750005T3 (xx)
HK (1) HK1210804A1 (xx)
IL (3) IL236975B (xx)
PL (1) PL3591057T3 (xx)
WO (1) WO2014025663A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN10991A (xx) 2012-05-25 2015-09-25 Cellectis
US20150353940A1 (en) * 2013-08-05 2015-12-10 Absci, Llc Vectors for use in an inducible coexpression system
US20180282405A1 (en) * 2012-08-05 2018-10-04 Absci, Llc Cytoplasmic expression system
US11077144B2 (en) 2013-05-13 2021-08-03 Cellectis CD19 specific chimeric antigen receptor and uses thereof
JP6788255B2 (ja) * 2015-11-19 2020-11-25 国立大学法人信州大学 新規ベクター及びこれを用いた可溶化タンパク質の製造方法
CN106190940B (zh) * 2016-07-19 2019-06-14 北京三元基因药业股份有限公司 表达抗TNF抗体Fab片段的重组大肠杆菌工程菌
CA3035473A1 (en) 2016-09-13 2018-03-22 Allergan, Inc. Non-protein clostridial toxin compositions
EP3765077A4 (en) * 2018-03-14 2022-01-05 Technion Research & Development Foundation Limited PROGNOSTIC BIOMARKER IN CANCER
JP7174990B2 (ja) * 2018-07-23 2022-11-18 国立大学法人山口大学 原核生物用発現ベクター
MX2021003475A (es) 2018-09-25 2021-09-10 Absci Corp Metodos de purificacion de proteinas.
SG11202104493WA (en) * 2018-11-08 2021-05-28 Sutro Biopharma Inc E coli strains having an oxidative cytoplasm
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
CN111269294B (zh) * 2018-12-05 2023-03-28 广州中国科学院先进技术研究所 纤维寡糖转运蛋白LacY的突变位点、突变转运蛋白LacY及其制备方法和应用
EP3935154A1 (en) * 2019-04-04 2022-01-12 Braskem S.A. Metabolic engineering for simultaneous consumption of xylose and glucose for production of chemicals from second generation sugars
CN110616181A (zh) * 2019-09-27 2019-12-27 北京理工大学 一株基于大肠杆菌改造的工程菌株
CN112980891B (zh) * 2019-12-16 2023-12-12 中国科学院分子植物科学卓越创新中心 一种基于CRISPR-Cas的大肠杆菌基因组编辑工具
CN113122552B (zh) * 2021-04-21 2022-07-26 西北农林科技大学 黄瓜谷氧还蛋白基因CsGRX4及其灰霉菌感病性的应用
WO2023044431A2 (en) 2021-09-17 2023-03-23 Absci Corporation Composition of transfer rnas and use in production of proteins containing non-standard amino acids
WO2024006269A1 (en) * 2022-06-29 2024-01-04 Absci Corporation Affinity screening method
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
CN116875524B (zh) * 2023-09-08 2024-03-26 清华大学 一种在微生物中调控多基因表达的方法及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2660397A (en) 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
CN1064052C (zh) * 1997-09-29 2001-04-04 中国科学院微生物研究所 甲状旁腺素相关蛋白人源化抗体及其制备方法
US6872563B1 (en) * 1999-10-05 2005-03-29 President And Fellows Of Harvard College Compositions and methods for production of disulfide bond containing proteins in host cells
ES2295151T3 (es) 2000-03-24 2008-04-16 Xoma Technology Ltd. Metodos y celulas mejorados para la expresion de productos proteicos recombinantes.
US6979556B2 (en) * 2000-12-14 2005-12-27 Genentech, Inc. Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
WO2003018771A2 (en) * 2001-08-27 2003-03-06 Genentech, Inc. A system for antibody expression and assembly
IL165364A0 (en) * 2002-05-28 2006-01-15 Omrix Biopharmaceuticals Inc Method for obtaining anti-idiotype antibodies
EP1539794B1 (en) * 2002-07-03 2008-12-31 Dow Global Technologies Inc. Benzoate- and anthranilate-inducible promoters
DE50307835D1 (de) * 2002-12-02 2007-09-13 Basf Ag L-rhamnose-induzierbare expressionssysteme
AU2006255060B2 (en) * 2005-06-06 2012-08-30 Pelican Technology Holdings, Inc. Mannitol induced promoter systems in bacterial host cells
US7351563B2 (en) 2005-06-10 2008-04-01 The Board Of Trustees Of The Leland Stanford Junior University Cell-free extracts and synthesis of active hydrogenase
WO2007005837A2 (en) 2005-07-01 2007-01-11 The Regents Of The University Of California Inducible expression vectors and methods of use thereof
JP4270466B2 (ja) * 2005-09-02 2009-06-03 国立大学法人福井大学 ＮＡＤａｓｅ、ＳＮＩおよびＳＬＯ遺伝子を含むオペロンから発現するタンパク質の製造方法、それにより得られるタンパク質およびその使用
US7816117B2 (en) 2006-04-26 2010-10-19 President And Fellows Of Harvard College Prokaryotic host cells for expressing proteins rich in disulfide bonds
WO2008130629A2 (en) * 2007-04-19 2008-10-30 Codon Devices, Inc. Engineered nucleases and their uses for nucleic acid assembly
US8629245B2 (en) 2007-05-01 2014-01-14 Research Development Foundation Immunoglobulin Fc libraries
CN101960017B (zh) 2008-01-03 2017-06-09 康乃尔研究基金会有限公司 原核生物中的糖基化蛋白表达
FI20095615A0 (fi) * 2009-06-02 2009-06-02 Oulun Yliopisto Menetelmä luonnollisesti laskostuneiden proteiinien tuottamiseksi prokaryootti-isännässä
WO2011116184A2 (en) * 2010-03-17 2011-09-22 Cornell University Methods and compositions for targeted mutagenesis in bacteria
EP2386641A1 (en) 2010-05-11 2011-11-16 Université Catholique De Louvain Method for extracellular production of recombinant biomolecules in a microorganism
FI20115115A0 (fi) 2011-02-04 2011-02-04 Oulun Yliopisto Menetelmä disulfidisidoksia sisältävien proteiinien tuottamiseksi prokaryoottisytoplasmassa

Also Published As

Publication number Publication date
AU2019202844B2 (en) 2022-03-17
US20150225731A1 (en) 2015-08-13
EP3591057B9 (en) 2023-07-19
CN104603274B (zh) 2020-08-18
US20170159061A1 (en) 2017-06-08
AU2013299910A1 (en) 2015-03-12
ES2750005T3 (es) 2020-03-24
US10465197B2 (en) 2019-11-05
JP7032292B2 (ja) 2022-03-08
US20220090093A1 (en) 2022-03-24
DK3187586T3 (da) 2019-10-14
CN111748510A (zh) 2020-10-09
EP3187586A1 (en) 2017-07-05
WO2014025663A1 (en) 2014-02-13
CN104603274A (zh) 2015-05-06
JP2019068830A (ja) 2019-05-09
DK2880168T3 (en) 2017-04-18
US9617335B2 (en) 2017-04-11
US20200032276A1 (en) 2020-01-30
US20200063116A1 (en) 2020-02-27
US20160152701A1 (en) 2016-06-02
CN111748510B (zh) 2023-08-15
US20200172915A1 (en) 2020-06-04
US11214807B2 (en) 2022-01-04
EP3187586B1 (en) 2019-09-25
CA2880285A1 (en) 2014-02-13
EP2880168B1 (en) 2017-01-11
ES2954516T3 (es) 2023-11-22
IL264384A (en) 2019-02-28
AU2022204192A1 (en) 2022-07-07
US10604761B2 (en) 2020-03-31
EP4273257A2 (en) 2023-11-08
JP6457387B2 (ja) 2019-01-23
AU2013299910B2 (en) 2019-01-24
EP3591057C0 (en) 2023-06-07
EP4273257A3 (en) 2024-02-28
US20230340501A1 (en) 2023-10-26
JP2022068332A (ja) 2022-05-09
CA2880285C (en) 2022-11-01
US11447781B2 (en) 2022-09-20
JP2015524281A (ja) 2015-08-24
IL276141A (en) 2020-09-30
IL276141B (en) 2022-03-01
EP2880168A1 (en) 2015-06-10
IL236975A0 (en) 2015-03-31
IL236975B (en) 2019-06-30
EP3591057A1 (en) 2020-01-08
AU2019202844A1 (en) 2019-05-16
PL3591057T3 (pl) 2023-10-02
ES2621320T3 (es) 2017-07-03
IL264384B (en) 2020-08-31
EP3591057B1 (en) 2023-06-07

Similar Documents

Publication Publication Date Title
IL276141B (en) A reciprocal expression system that can be influenced
IL233614A0 (en) anti-rocket system
GB201200831D0 (en) Improved positioning system
IL218530A0 (en) Aquaclture system
SG11201405237PA (en) Control system
EP2832118A4 (en) MESSAGING SYSTEM BASED ON THE CONTEXT
GB201213846D0 (en) Location system
GB201217418D0 (en) System
EP2803201A4 (en) IMPROVED RETURN SYSTEM
SG2012077830A (en) Instant messaging system
EP2854255A4 (en) CONTROL SYSTEM
ZA201504003B (en) Stabilizing system
EP2904178A4 (en) RETENTION SYSTEM
ZA201500983B (en) Carrying system
ZA201500982B (en) Carrying system
GB201214089D0 (en) Turbpcharger by-pass system
GB2521548B (en) Steering system
GB201216835D0 (en) Tagging system
GB201217413D0 (en) Control system
EP2849147A4 (en) SYSTEM FOR SELECTION OF GUIDELINES
GB2498748B (en) Connection system
GB201205048D0 (en) Hounds free system
GB201220319D0 (en) Passerelle system
GB201220308D0 (en) Passerelle system
GB201220312D0 (en) Passerelle system